| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 1,090,455 | 1,229,611 | 1,213,002 | | Cost of Revenue | 434,398 | 490,696 | 490,843 | | | Gross Profit | 656,057 | 738,915 | 722,159 | | | Operating Expenses | | Research Development | 86,453 |
-
|
-
| | Selling General and Administrative | 374,427 | 551,420 | 589,379 | | Non Recurring | 10,037 | 42,645 |
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 185,140 | 144,850 | 132,780 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 27,581 | 35,542 | 60,277 | | Earnings Before Interest And Taxes | 212,721 | 180,392 | 193,057 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | 212,721 | 180,392 | 193,057 | | Income Tax Expense | 73,074 | 45,998 | 34,965 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 139,647 | 134,394 | 158,092 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 139,647 | 134,394 | 158,092 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $139,647 | $134,394 | $158,092 |
|
1.48% Nasdaq 
Income Statement
